Decreased SDF-1 production by bone marrow stromal cells in response to TNF overexpression may therefore be one of the mechanisms mediating release of OCPs to the peripheral blood in mice with TNF-induced arthritis or in patients with inflammatory arthritis. Here, CXCL12 is linked to arthritic joint disease.